Skip to main content Accessibility help
×
Home

Review of smoking cessation treatments for people with mental illness

  • Jonathan Campion, Ken Checinski and Jo Nurse

Abstract

This article reviews the current literature regarding treatments for smoking cessation in both the general population and in those with mental health problems. The gold-standard treatment for the general population is pharmacotherapy (nicotine replacement therapy, bupropion or varenicline) coupled with individual or group psychological support. This is also effective in helping people with mental illness to reduce or quit smoking, but care must be taken to avoid adverse medication interactions and to monitor antipsychotic medication in particular as cigarette consumption reduces.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Review of smoking cessation treatments for people with mental illness
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Review of smoking cessation treatments for people with mental illness
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Review of smoking cessation treatments for people with mental illness
      Available formats
      ×

Copyright

References

Hide All
Abbot, N. C., Stead, L. F., White, A. R. et al (1998) Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews, issue 2, CD001008. Update Software.
Anonymous (2000) Bupropion to aid smoking cessation. Drugs and Therapeutics Bulletin, 38, 7375.
Baker, A., Richmond, R., Haile, M. et al (2006) A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 19341942.
Bazire, S. (2003) Psychotropic Drug Directory 2003/2004. Fivepin Publishing.
Breslau, N., Novak, S. P. & Kessler, R. C. (2004) Psychiatric disorders and stages of smoking. Biological Psychiatry, 55, 6976.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2008) British National Formulary. BMJ Books & Pharmaceutical Press.
Brown, S., Barraclough, B. & Inskip, H. (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212217.
Cahill, K. & Ussher, M. (2007) Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database of Systematic Reviews, issue 4, CD005353. Wiley InterScience.
Cahill, K., Stead, L. & Lancaster, T. (2007) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, issue 1, CD006103. Wiley InterScience.
Cox, L. S., Patten, C. A., Niaura, R. S. et al (2004) Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. Journal of General Internal Medicine, 19, 828834.
Cuijpers, P., Smit, F., ten Have, M. et al (2007) Smoking is associated with first-ever incidence of mental disorders: a prospective population-based study. Addiction, 102, 13031309.
David, S., Lancaster, T., Stead, L. F. et al (2006) Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews, issue 4, CD003086. Wiley InterScience.
Dolan, S. L., Sacco, K. A., Termine, A. et al (2004) Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. Schizophrenia Research, 70, 263275.
Evins, A. E., Cather, C., Rigotti, N. A. et al (2004) Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65, 307311.
Evins, A. E., Cather, C., Deckersbach, T. et al (2005) A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25, 218225.
Evins, A. E., Culhane, M.A., Birnbaum, A. et al (2007) A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology, 27, 380386.
Ferguson, D., Goodwin, R. & Horwood, L. (2003) Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychological Medicine, 33, 13571367.
Foulds, J. G. K., Steinberg, M. B., Richardson, D. et al (2006) Factors associated with quitting smoking at a tobacco dependence treatment clinic. American Journal of Health Behaviour, 30, 400412.
Freedman, R. (2007) Exacerbation of schizophrenia by varenicline. American Journal of Psychiatry, 164, 1269.
George, T. P., Ziedonis, D. M., Feingold, A. et al (2000) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 18351842.
Grimshaw, G. M. & Stanton, A. (2006) Tobacco cessation interventions for young people. Cochrane Database of Systematic Reviews, issue 4, CD003289. Wiley InterScience.
Haas, A. L., Munoz, R. F., Humfleet, G. L. et al (2004) Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting and Clinical Psychology, 72, 563570.
Hall, S. M., Tsoh, J. Y., Prochaska, J. J. et al (2006) Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. American Journal of Public Health, 96, 18081814.
Haslemo, T., Eikeseth, P. H., Tanum, L. et al (2006) The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. European Journal of Clinical Pharmacology, 62, 10491053.
Hayford, K. E., Patten, C. A., Rummans, T. A. et al (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry, 174, 173178.
Hey, K. & Perera, R. (2005) Competitions and incentives for smoking cessation. Cochrane Database of Systematic Reviews, issue 2, CD004307. Wiley InterScience.
Hitsman, B., Borrelli, B., McChargue, D. E. et al (2003) History of depression and smoking cessation outcome: a meta-analysis. Journal of Consulting and Clinical Psychology, 71, 657663.
Hughes, J. R. (2007) Depression during tobacco abstinence. Nicotine and Tobacco Research, 9, 443446.
Hughes, J., Stead, L. & Lancaster, T. (2007) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, issue 1, CD000031. Wiley InterScience.
Jochelson, J. & Majrowski, B. (2006) Clearing the Air. Debating Smoke-Free Policies in Psychiatric Units. King's Fund.
Kinnunen, T., Doherty, K., Militello, F. S. et al (1996) Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. Journal of Consulting and Clinical Psychology, 64, 791798.
Kohen, I. & Kremen, N. (2007) Varenicline-induced manic episode in a patient with bipolar disorder. American Journal of Psychiatry, 164, 12691270.
Lancaster, T. & Stead, L. F. (2004) Physician advice for smoking cessation. Cochrane Database of Systematic Reviews, issue 4, CD000165. Update Software.
Lancaster, T. & Stead, L. F. (2005a) Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, issue 2, CD001292. Wiley InterScience.
Lancaster, T. & Stead, L. F. (2005b) Self help interventions for smoking cessation. Cochrane Database of Systematic Reviews, issue 3, CD001118. Wiley InterScience.
Lancaster, T., Hajek, P., Stead, L. F. et al (2006) Prevention of relapse after quitting smoking: a systematic review of trials. Archives of Internal Medicine, 166, 828835.
Lasser, K., Boyd, J. W., Woolhandler, S. et al (2000) Smoking and mental illness. A population-based prevalence study. JAMA, 284, 26062610.
Lawn, S. & Pols, R. (2005) Smoking bans in psychiatric settings? A review of the research. Australian and New Zealand Journal of Psychiatry, 39, 866–855.
Martinez-Raga, J., Keaney, F., Sutherland, G. et al (2003) Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile. Addiction Biology, 8, 1321.
McNeill, A. (2004) Smoking and Patients with Mental Health Problems. Health Development Agency.
Medicines and Healthcare products Regulatory Agency & Committee on Safety of Medicines (2005) Report of the Committee on Safety of Medicines Working Group on Nicotine Replacement Therapy. MHRA.
Raftery, J. (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ, 323, 13001303.
Rice, V. H. & Stead, L. F. (2008) Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, issue 1, CD001188. Wiley InterScience.
Richmond, R. & Zwar, N. (2003) Review of bupropion for smoking cessation. Drug and Alcohol Review, 22, 203220.
Schall, U. S., Pries, E., Katta, T. et al (1996) Pharmacokinetic and pharmacodynamic interactions in an outpatient maintenance therapy of intravenous heroin users with levomethadone. Addiction Biology, 1, 105113.
Seppala, N. H., Leinonen, E. V., Lehtonen, M. L. et al (1999) Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients. Pharmacology and Toxicology, 85, 244246.
Stead, L. & Lancaster, T. (2005) Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews, issue 2, CD001007. Wiley InterScience.
Stead, L. & Lancaster, T. (2007) Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, issue 3, CD005231. Wiley InterScience.
Stead, L., Perera, R. & Lancaster, T. (2006) Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, issue 2, CD001007. Wiley InterScience.
Stead, L., Perera, R. & Lancaster, T. (2007) A systematic review of interventions for smokers who contact quitlines. Tobacco Control, 16, 38.
Stead, L., Perera, R., Bullen, C. et al (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, issue 1, CD000146. Wiley InterScience.
Steinberg, M. L., Williams, J. M. & Ziedonis, D. M. (2004) Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control, 13, 206.
Strasser, A. A., Kaufmann, V., Jepson, C. et al (2005) Effects of different nicotine replacement therapies on postcessation psychological responses. Addictive Behaviour, 30, 917.
Taylor, A. H., Ussher, M. H. & Faulkner, G. (2007) The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction, 102, 534543.
Taylor, D., Paton, C. & Kerwin, R. (2007) Maudsley Prescribing Guidelines (9th edn). Informa Healthcare.
Wang, D., Connock, M., Barton, P. et al (2008) ‘Cut down to quit’ with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technology Assessment, 12(2), 1156.
West, R. & Shiffman, S. (2001) Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology, 155, 115122.
West, R., McNeill, A. & Raw, M. (2004) Smoking Cessation Guidelines for Scotland: 2004 Update. NHS Health Scotland & ASH Scotland.
White, A. R., Rampes, H. & Campbell, J. L. (2006) Acupuncture and related interventions for smoking cessation. Cochrane Database of Systematic Reviews, issue 1, CD000009. Wiley InterScience.
Wilhelm, K., Arnold, K., Niven, H. et al (2004) Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. Australian and New Zealand Journal of Psychiatry, 38, 896905.
Wilhelm, K., Wedgwood, L., Niven, H. et al (2006) Smoking cessation and depression: current knowledge and future directions. Drug and Alcohol Review, 25, 97107.
Williams, J. M. & Foulds, J. (2007) Successful tobacco dependence treatment in schizophrenia. American Journal of Psychiatry, 164, 222227.
Williams, J. M. & Hughes, J. R. (2003) Addressing tobacco use in mental health and addiction settings. Psychiatric Annals, 33, 457466.
Woolacott, N. F., Jones, L., Forbes, C. A. et al (2002) The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment, 6(4), 1183.
Zullino, D. F., Delssert, D., Eap, C. B. et al (2002) Tobacco and cannabis cessation can lead to intoxication with clozapine or olanzapine. International Clinical Psychopharmacology, 17, 141143.
Zwartz, L. H., Noell, J. W., Schroeder, S. W. et al (2006) A randomised control study of a fully automated internet based smoking cessation programme. Tobacco Control, 15, 712.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Review of smoking cessation treatments for people with mental illness

  • Jonathan Campion, Ken Checinski and Jo Nurse
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *